ArticleThe journal of headache and pain2021

Preventive treatment with CGRP monoclonal antibodies restores brain stem habituation deficits and excitability to painful stimuli in migraine: results from a prospective case-control study.

Anne Thiele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.